LIFECORE BIOMEDICAL, INC. Other Accrued Liabilities, Current
LIFECORE BIOMEDICAL, INC. (LFCR) had Other Accrued Liabilities, Current of $1.92 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Payables and Accruals › Accrued Liabilities, Current
us-gaap:OtherAccruedLiabilitiesCurrent · last filed 2026-08-05
- 2026-06-30: Other Accrued Liabilities, Current $1.92M.
- 2026-03-31: Other Accrued Liabilities, Current $1.56M.
- 2025-12-31: Other Accrued Liabilities, Current $1.76M; Other Accrued Liabilities, Current as first filed $1.50M.
- 2025-09-30: Other Accrued Liabilities, Current $2.86M.
| Period end | Other Accrued Liabilities, Current | Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.92M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $1.56M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $1.76M 10-Q · filed 2026-08-05 | $1.50M 10-KT · filed 2026-03-16 |
| 2025-09-30 | $2.86M 10-Q · filed 2025-11-06 | |
| 2025-05-25 | $1.84M 10-KT · filed 2026-03-16 | $2.17M 10-K · filed 2025-08-07 |
| 2025-02-23 | $2.13M 10-Q · filed 2025-04-03 | |
| 2024-11-24 | $9.87M 10-Q · filed 2025-01-02 | |
| 2024-08-25 | $11.38M 10-Q · filed 2024-10-04 | |
| 2024-05-26 | $1.55M 10-KT · filed 2026-03-16 | $9.99M 10-K · filed 2024-08-26 |
| 2024-02-25 | $8.89M 10-Q · filed 2024-08-09 | |
| 2023-11-26 | $7.66M 10-Q · filed 2024-08-09 | |
| 2023-08-27 | $4.86M 10-Q · filed 2024-08-09 | |
| 2023-05-28 | $7.14M 10-K · filed 2024-08-26 | |
| 2023-02-26 | $11.63M 10-K · filed 2024-03-20 | $12.01M 10-Q · filed 2023-06-02 |
| 2022-11-27 | $9.37M 10-K · filed 2024-03-20 | $10.43M 10-Q · filed 2023-03-16 |
| 2022-08-28 | $6.62M 10-K · filed 2024-03-20 | $7.83M 10-Q · filed 2022-10-07 |
| 2022-05-29 | $6.48M 10-K · filed 2024-03-20 | $7.65M 10-K · filed 2022-09-14 |
| 2022-02-27 | $12.99M 10-K · filed 2024-03-20 | $13.73M 10-Q · filed 2022-04-07 |
| 2021-11-28 | $3.88M 10-K · filed 2024-03-20 | $9.80M 10-Q · filed 2022-01-07 |
| 2021-08-29 | $4.71M 10-K · filed 2024-03-20 | $10.86M 10-Q · filed 2021-10-05 |
| 2021-05-30 | $3.01M 10-K · filed 2024-03-20 | $8.00M 10-K · filed 2021-07-29 |
| 2021-02-28 | $5.78M 10-K · filed 2024-03-20 | $11.19M 10-Q · filed 2021-04-08 |
| 2020-11-29 | $6.12M 10-K · filed 2024-03-20 | $12.71M 10-Q · filed 2021-01-07 |
| 2020-08-30 | $3.67M 10-K · filed 2024-03-20 | $9.61M 10-Q · filed 2020-10-07 |
| 2020-05-31 | $9.98M 10-K · filed 2021-07-29 | |
| 2020-02-23 | $11.11M 10-Q · filed 2020-04-03 | |
| 2019-11-24 | $10.70M 10-Q · filed 2020-01-02 | |
| 2019-08-25 | $8.79M 10-Q · filed 2019-10-03 | |
| 2019-05-26 | $10.00M 10-K · filed 2020-08-14 | $10.08M 10-K · filed 2019-08-01 |
| 2019-02-24 | $10.41M 10-Q · filed 2019-04-04 | |
| 2018-11-25 | $9.92M 10-Q · filed 2019-01-07 | |
| 2018-08-26 | $8.85M 10-Q · filed 2018-10-05 | |
| 2018-05-27 | $8.71M 10-K · filed 2019-08-01 | |
| 2018-02-25 | $10.37M 10-Q · filed 2018-04-05 | |
| 2017-11-26 | $8.47M 10-Q · filed 2018-01-05 | |
| 2017-08-27 | $9.75M 10-Q · filed 2017-09-28 | |
| 2017-05-28 | $9.04M 10-K · filed 2018-08-09 | $9.13M 10-K · filed 2017-08-11 |
| 2017-02-26 | $10.90M 10-Q · filed 2017-04-07 | |
| 2016-11-27 | $8.42M 10-Q · filed 2017-01-05 | |
| 2016-08-28 | $9.14M 10-Q · filed 2016-09-29 | |
| 2016-05-29 | $7.77M 10-K/A · filed 2018-03-15 | |
| 2016-02-28 | $7.28M 10-Q · filed 2016-03-30 | |
| 2015-11-29 | $5.88M 10-Q · filed 2016-01-07 | |
| 2015-08-30 | $4.85M 10-Q · filed 2015-10-01 | |
| 2015-05-31 | $5.21M 10-K · filed 2016-08-01 | $3.98M 10-K · filed 2015-07-31 |
| 2015-03-01 | $4.79M 10-Q · filed 2015-04-02 | |
| 2014-11-30 | $4.94M 10-Q · filed 2015-01-09 | |
| 2014-08-31 | $4.41M 10-Q · filed 2014-10-08 | |
| 2014-05-25 | $4.87M 10-K · filed 2015-07-31 | |
| 2014-02-23 | $4.44M 10-Q · filed 2014-03-28 | |
| 2013-11-24 | $4.51M 10-Q · filed 2014-01-03 | |
| 2013-08-25 | $3.22M 10-Q · filed 2013-09-26 | |
| 2013-05-26 | $2.33M 10-K · filed 2014-08-01 | |
| 2013-02-24 | $2.45M 10-Q · filed 2013-04-04 | |
| 2012-11-25 | $4.51M 10-Q · filed 2013-01-04 | |
| 2012-08-26 | $7.57M 10-Q/A · filed 2013-01-02 | |
| 2012-05-27 | $18.64M 10-K · filed 2013-08-07 | |
| 2012-02-26 | $12.72M 10-Q · filed 2012-03-28 | |
| 2011-11-27 | $13.30M 10-Q · filed 2012-01-05 | |
| 2011-08-28 | $13.62M 10-Q · filed 2011-10-05 | |
| 2011-05-29 | $3.58M 10-K · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |